Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating fluid responsiveness in shock patients using tissue Doppler

Official title: Diagnostic Performance of the Mitral Annulus Velocity Variation Measured by Tissue Doppler to Evaluate the Fluid Responsiveness During the Initial Management of Shock in Patients Admitted to the Emergency Department

Run by Centre Hospitalier Universitaire de Nīmes · NCT05888974 · Data updated 2026-11-12

This study is testing if measuring heart movement with ultrasound can help doctors tell if patients in shock will benefit from receiving extra fluids.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment187 (estimated)
SponsorCentre Hospitalier Universitaire de Nīmes
Academic / other
Locations1 site (Nîmes)
StatusRecruiting
StartedAugust 1, 2023
Main results expectedAugust 8, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 4, 2025
Trial IDNCT05888974 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are experiencing shock with a mean blood pressure less than 65 mmHg.

Probably not a fit

Patients with cardiogenic or obstructive shock, or those who have contraindications to fluid filling, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assesses the diagnostic performance of mitral annulus velocity variation measured by tissue Doppler to evaluate fluid responsiveness in patients experiencing shock. It involves using trans thoracic ultrasound to monitor changes in the mitral annulus velocity before and after administering a fluid challenge. The goal is to determine if the variation in velocity can reliably indicate whether a patient will respond positively to fluid resuscitation. The study aims to establish a diagnostic performance threshold defined by an area under the ROC curve greater than 0.75.

Why it matters

Potential benefit: If successful, this approach could improve the management of shock patients by providing a reliable method to assess fluid responsiveness.

How similar studies have gone: While this approach is novel in the context of shock management, similar studies using tissue Doppler for fluid responsiveness have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient has been informed of the study and does not refuse to participate.
* Patient is at least ≥ 18 years of age.
* The patient must be beneficiary of a health insurance plan.
* Patient has shock with a mean blood pressure less than 65 mmHg (\<)
* The patient does not have acute intracranial pathology
* The referring physician has decided on a vascular filling with 500mL of crystalloids (NaCl 0.9% or Ringer lactate)

Exclusion Criteria:

* The patient has already received 2 vascular fillings since the beginning of his management
* The patient is in shock and has a contraindication to vascular filling : shock of a cardiogenic or obstructive nature
* The patient has an intracranial pathology requiring maintain a MAP ≥ 80 mmHg
* The patient is intubated or on Non-Invasive Ventilation before the vascular filling
* The patient is under court protection
* The patient is pregnant, parturient or nursing

Where it's running

  • CHU de Nîmes
    Nîmes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.